FDA inspection
Tarsal Pharmaceuticals, Inc.: FDA inspection ending Jan 29, 2024
FDA inspection 1232814 · No Action Indicated (NAI) · Oceanside, CA
Key facts
| Inspection ID | 1232814 |
|---|---|
| Firm | Tarsal Pharmaceuticals, Inc. |
| FEI number | 3014528861 |
| Address | 3909 Oceanic Dr Ste 401 |
| City | Oceanside |
| State | CA |
| ZIP | 92056 |
| Country | United States |
| Fiscal year | 2024 |
| Inspection end date | Jan 29, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Food Composition, Standards, Labeling and Econ |
| Product type | Food/Cosmetics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data